|
[Related PubMed/MEDLINE] Total Number of Papers: 180
|
|
|
[Display Entries]
|
>> all entries
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2017 |
Expression profile of matricellular proteins in hypertrophied right ventricle of monocrotaline-induced pulmonary hypertensive rats. |
ECM, MCT, OPN, RV, TSP |
2 |
2015 |
Does Tenascin have Clinical Implications in Pathological Grade of Glioma Patients?: A Systematic Meta-Analysis. |
CIs, ECM, ORs, SMDs |
3 |
2015 |
Immunoexpression of tenascin as a predictor of the malignancy potential of oral leukoplakia associated with a tobacco habit. |
ECM |
4 |
2015 |
Immunohistochemical Evaluation of Fibronectin and Tenascin Following Direct Pulp Capping with Mineral Trioxide Aggregate, Platelet-Rich Plasma and Propolis in Dogs' Teeth. |
DPC, FN, MTA, PRP |
5 |
2015 |
Tenascin-X: beyond the architectural function. |
TGF |
6 |
2014 |
Targeting the extracellular matrix: matricellular proteins regulate cell-extracellular matrix communication within distinct niches of the intervertebral disc. |
ECM, POSTN, TSP |
7 |
2014 |
The effect of five proteins on stem cells used for osteoblast differentiation and proliferation: a current review of the literature. |
BSP, FN, MSCs, OPN |
8 |
2013 |
Tenascin and fibronectin expression after pulp capping with different hemostatic agents: a preliminary study. |
CH, FN |
9 |
2012 |
Promoting effects of carminic acid-enriched cochineal extracts on capsular invasive thyroid carcinomas through targeting activation of angiogenesis in rats. |
CA, CA, CA, CE, CICs, PHBP, PTEN |
10 |
2012 |
[Expression of some biomarkers in primary colon adenocarcinomas and their lymph node metastases]. |
CAC, EGFR, TS, VEGF |
11 |
2011 |
Histologic response and tenascin and fibronectin expression after pulp capping in pig primary teeth with mineral trioxide aggregate or calcium hydroxide. |
CH, FN, MTA |
12 |
2011 |
Immunohistochemical expression of fibronectin and tenascin in human tooth pulp capped with mineral trioxide aggregate and a novel endodontic cement. |
FN, MTA, NEC |
13 |
2010 |
Reduction of protein kinase C delta attenuates tenascin-C stimulated glioma invasion in three-dimensional matrix. |
MMP, PKC |
14 |
2009 |
Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas. |
DC, MMP-9, NDC |
15 |
2008 |
Alteration of inflammatory cytokine production in the injured central nervous system of tenascin-deficient mice. |
CNS, IL, WT |
16 |
2008 |
Synthesis of tenascin and laminin beta2 chain in human bronchial epithelial cells is enhanced by cysteinyl leukotrienes via CysLT1 receptor. |
CysLTs, LN, LTD4 |
17 |
2007 |
Central giant cell granuloma of the jaws and giant cell tumor of long bones: an immunohistochemical comparative study. |
CGCG, FN, GCT |
18 |
2007 |
Immunohistochemical expression of tenascin in melanocytic tumours of dogs. |
vWF |
19 |
2007 |
Tenascin-C is required for proliferation of astrocytes in primary culture. |
--- |
20 |
2006 |
Effect of GaAIAs laser on reactional dentinogenesis induction in human teeth. |
Col III, FN, GaAlAs, SABC |
21 |
2006 |
Histological changes in the liver of fetuses of alcohol-treated pregnant rats. |
PAP |
22 |
2006 |
Immunohistochemical assessment of fibronectin and tenascin and their integrin receptors alpha5beta1 and alpha9beta1 in gastric and colorectal cancers with lymph node and liver metastases. |
FN, IF |
23 |
2006 |
Tenascin and fibronectin in pleomorphic adenoma of the salivary gland. |
FN |
24 |
2005 |
Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotype. |
DC, MC |
25 |
2005 |
Cellular and molecular tunnels surrounding the forebrain commissures of human fetuses. |
CS, ECM, FN, GFAP, MAP-2, NeuN, NF, VN, wpo |
26 |
2005 |
Serum tenascin-C as a potential predictive marker of angiogenesis in non-small cell lung cancer. |
CEA, HUVEC, MVD, NSCLC, OPN, SLX, VEGF |
27 |
2005 |
The effects of alcohol on rat placenta. |
--- |
28 |
2004 |
Different titanium surfaces modulate the bone phenotype of SaOS-2 osteoblast-like cells. |
CoI, FN, SB, TPS, VN |
29 |
2004 |
Glomerular capillary tenascin staining in renal allografts and its correlation with capillary loop 'double contours', proteinuria and graft outcome. |
CAN, GC-TN |
30 |
2004 |
In vitro immunoexpression of extracellular matrix proteins in dental pulpal and gingival human fibroblasts. |
ECM, FN, LM, ONEC |
31 |
2004 |
Regulation of tenascin expression in cultured rat dental pulp cells. |
bFGF, EGF, FN, HGF, RA, RT-PCR, TGF-beta1 |
32 |
2003 |
A study of the extracellular matrix in salivary gland tumors. |
ACC, BCA, BM, ECM, FN, LN, PA, PLGA |
33 |
2003 |
Expression of fibronectin and tenascin as a demonstration of vital reaction in rat skin and muscle. |
FN |
34 |
2003 |
Matricellular proteins as modulators of wound healing and the foreign body response. |
ECM, OPN, TSP |
35 |
2003 |
Topographic and zonal distribution of tenascin in human articular cartilage from femoral heads: normal versus mild and severe osteoarthritis. |
OA |
36 |
2002 |
Changes in tenascin-C isoform expression in invasive and preinvasive breast disease. |
DCIS, TN16 |
37 |
2002 |
Expression of tenascin and fibronectin in nasal polyps. |
EOS, FN, NP |
38 |
2002 |
Immunohistochemical detection of fibronectin and tenascin in incised human skin injuries. |
FN |
39 |
2002 |
Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. |
CD, CD44s, Coll, ECM, FN, LN |
40 |
2002 |
Tenascin expression in normal, hyperplastic, and neoplastic endometrium. |
ECM |
41 |
2002 |
The role of matricellular proteins thrombospondin-1 and osteonectin during RPE cell migration in proliferative vitreoretinopathy. |
SPARC, TSP-1 |
42 |
2002 |
[Expression of extracellular matrix glycoprotein tenascin in the laryngeal cancer]. |
--- |
43 |
2002 |
[Expression of tenascin and fibronectin in nasal polyps]. |
EOS, FN |
44 |
2001 |
The disintegrin kistrin inhibits neurite extension from spiral ganglion explants cultured on laminin. |
LN, SG |
45 |
2000 |
Alterations in extracellular matrix components in transplant glomerulopathy. |
ECM, FN |
46 |
2000 |
Contribution of heparan sulfate to the non-permissive role of the midline glia to the growth of midbrain neurites. |
CS, FN, GAGs, HS, LN |
47 |
2000 |
Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. |
MMPs, OPN, SMCs |
48 |
2000 |
Expression of the extracellular matrix protein tenascin in laryngeal epithelial lesions: correlation with fibronectin, CD44, cathepsin D and proliferation indices. |
CD, PCNA |
49 |
2000 |
Immunohistochemical localization of tenascin, fibronectin, and type III collagen in human dental pulp. |
FN |
50 |
2000 |
Tenascin expression in intraepithelial neoplasia and invasive carcinoma of the uterine cervix. |
CIN |
51 |
2000 |
Tenascin expression patterns and cells of monocyte lineage: relationship in human gliomas. |
ECM |
52 |
2000 |
Tenascin patterns of expression in duct carcinoma in situ of the breast. |
DCIS |
53 |
2000 |
The distribution of extracellular matrix proteins and CD44S expression in human astrocytomas. |
AA, FN, GB, LN |
54 |
2000 |
The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. |
ECM |
55 |
2000 |
[Expression of glial, neurospecific, and extracellular antigens during retinal regeneration in adult newts]. |
GFAP |
56 |
1999 |
Corneal wound healing in tenascin knockout mouse. |
FN, KO |
57 |
1999 |
Enhanced tenascin expression correlates with inflammation in primary sclerosing cholangitis. |
alpha-SMA, ECM, PSC |
58 |
1999 |
Expression of integrin alpha9 subunit and tenascin in oral leukoplakia, lichen planus, and squamous cell carcinoma. |
SCC |
59 |
1999 |
Extracellular matrix and development of lamination in the dorsal lateral geniculate nucleus in the tree shrew (Tupaia belangeri). |
PNA, VIM |
60 |
1999 |
Mechanical loading regulates tenascin-C expression in the osteotendinous junction. |
OTJ |
61 |
1999 |
Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis. |
MMPs, PA, SMCs |
62 |
1999 |
Regular albuterol or nedocromil sodium--effects on airway subepithelial tenascin in asthma. |
FEV1 |
63 |
1999 |
Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines. |
BSA, FSH, hCG, IGF, TGF |
64 |
1999 |
Tenascin is expressed in the mesenchyme of the embryonic lung and down-regulated by dexamethasone in early organogenesis. |
--- |
65 |
1999 |
Tenascin labelling in colorectal biopsies: a useful marker in the diagnosis of collagenous colitis. |
--- |
66 |
1999 |
TGF-beta2, tenascin, and integrin beta1 expression in superior limbic keratoconjunctivitis. |
SLK, TGF |
67 |
1999 |
The expression of transforming growth factor beta (TGF-beta) in the synovial membrane of human temporomandibular joint with internal derangement: a comparison with tenascin expression. |
TGF-beta, TMJ |
68 |
1998 |
Cleft palate formation in fetal Br mice with midfacial retrusion: tenascin, fibronectin, laminin, and type IV collagen immunolocalization. |
ECM, FN, LN, MES |
69 |
1998 |
Corneal wound healing after laser in situ keratomileusis in rabbits. |
EDA-cFn, LASIK |
70 |
1998 |
Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. |
CS, ECM, FN, pw |
71 |
1998 |
Domains of tenascin involved in glioma migration. |
FNIII |
72 |
1998 |
Extracellular matrix in renal cell carcinomas. |
BM, ECM, EDA-Fn, Int, LN, RCCs |
73 |
1998 |
Fibrous wound repair associated with biodegradable poly-L/D-lactide copolymer implants: study of the expression of tenascin and cellular fibronectin. |
cFN, ECM, mAb, PLA |
74 |
1998 |
Induction of tenascin in rat lungs undergoing bleomycin-induced pulmonary fibrosis. |
Col III |
75 |
1998 |
Molecular tunnels and boundaries for growing axons in the anterior commissure of hamster embryos. |
AC, CSPG, FN, GFAP, LN |
76 |
1998 |
Reduced mRNA expression of neuropeptide Y in the limbic system of tenascin gene disrupted mouse brain. |
NPY |
77 |
1998 |
Surface topography and serum concentration affect the appearance of tenascin in human gingival fibroblasts in vitro. |
HGF |
78 |
1998 |
Tenascin and fibronectin expression in human mesothelial cells and pleural mesothelioma cell-line cells. |
cDNA, ECM, FN, TGF-beta, TNF-alpha |
79 |
1998 |
Tenascin pattern of expression and established prognostic factors in invasive breast carcinoma. |
IDCC |
80 |
1998 |
Tenascin suppresses CD3-mediated T cell activation. |
FN, LFA-1, VLA |
81 |
1998 |
The effects of central administration of neuropeptide Y on behavior of tenascin-gene knockout mice. |
NPY |
82 |
1997 |
Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast. |
ECM, FN |
83 |
1997 |
Effect of snuff and smoking on tenascin expression in oral mucosa. |
--- |
84 |
1997 |
Effects of cholecystokinin-B receptor antagonist on dopamine system in tenascin mutant mice. |
CCK, DA, TH |
85 |
1997 |
Epicutaneous application of leukotriene B4 induces patterns of tenascin and a heparan sulfate proteoglycan epitope that are typical for psoriatic lesions. |
HSPGs, LTB4 |
86 |
1997 |
Expression of tenascin in mesangial injury in experimental glomerulonephritis. |
MPGN |
87 |
1997 |
Morphologic pattern of tenascin as a diagnostic biomarker in colon cancer. |
--- |
88 |
1997 |
Multiple promoter elements differentially regulate the expression of the mouse tenascin gene. |
--- |
89 |
1997 |
Neuronal differentiation in SH-SY5Y human neuroblastoma cells induces synthesis and secretion of tenascin and upregulation of alpha(v) integrin receptors. |
EDA-Fn, Int, RA, TPA |
90 |
1997 |
Oxidative stress mediates monocrotaline-induced alterations in tenascin expression in pulmonary artery endothelial cells. |
DMTU, MCT, PAECs |
91 |
1997 |
Preprotachykinin A and cholecystokinin mRNAs in tenascin-gene knockout mouse brain. |
CCK, PPT |
92 |
1997 |
Tenascin-C expression in the cyst wall and fluid of human brain tumors correlates with angiogenesis. |
--- |
93 |
1997 |
Tenascin-C expression in ultrastructurally defined angiogenic and vasculogenic lesions. |
PI |
94 |
1997 |
Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. |
EGF, FN, PCNA |
95 |
1997 |
The change in tenascin expression in mouse uterus during early pregnancy. |
--- |
96 |
1997 |
The expression of tenascin and fibronectin in keratoconus, scarred and normal human cornea. |
EDA-Fn, EDB-Fn, FN, mAbs, onc-Fn |
97 |
1997 |
The specific expression of tenascin in the synovial membrane of the temporomandibular joint with internal derangement: an immunohistochemical study. |
TMJ |
98 |
1997 |
Transforming growth factor and tenascin in synovial chondromatosis of the temporomandibular joint. Report of a case. |
SC, TGF, TMJ |
99 |
1997 |
Tyrosine hydroxylase activity and its mRNA level in dopaminergic neurons of tenascin gene knockout mouse. |
TH |
100 |
1996 |
Abnormal behavior and neurotransmissions of tenascin gene knockout mouse. |
DA |
|